Basic Fibroblast Growth Factor‐Releasing Bioabsorbable Polyglycolic Acid Dura Mater Enhances Neural Progenitor Cell Proliferation and Neuroprotection After Brain Injury
Brain and Behavior · 2025
DOI: 10.1002/brb3.71008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Yoshiro Ito und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Dura Mater, Neural Stem Cells, Brain Injuries. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Traumatic brain injury harms health, causes disability, and burdens health care systems and economies. Although new treatments for brain injury have been developed, their therapeutic efficacy remains insufficient. Herein, we demonstrate the therapeutic efficacy of artificial dura mater with varying basic fibroblast growth factor (bFGF)‐releasing capabilities using a brain injury model.
Methods
Artificial dura mater of lower (FGF‐L) and higher (FGF‐H) bFGF‐releasing capabilities was prepared via oxygen plasma treatment for polyglycolic acid nonwoven fabric followed by bFGF adsorption. Mice received either bFGF‐releasing dura mater (FGF‐L, FGF‐H) or bFGF‐free dura mater (FGF‐C) at the site of the induced brain injury.
Results
Neurological functions significantly improved in the FGF‐L and FGF‐H groups compared with those in the FGF‐C group on Day 14. No significant difference was observed in the brain injury area between the FGF‐C group and either the FGF‐L or FGF‐H group. The number of SRY‐box transcription factor 2‐positive cells in the cortex was significantly larger in the FGF‐L and FGF‐H groups than in the FGF‐C group on Day 7. The terminal transferase dUTP nick‐end labeling‐positive cell ratio was significantly lower in the FGF‐H group than in the FGF‐C group on Day 14. The occludin‐positive and ZO‐1‐positive cell ratios were significantly greater in the FGF‐H group than in the FGF‐C group on Day 14, suggesting improved blood–brain barrier integrity.
Conclusion
The bFGF‐releasing dura mater enhanced neural progenitor cell proliferation, inhibited apoptosis and blood–brain barrier breakdown, and contributed to neurological function recovery in brain‐injured mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Research Institute of Core Technology for Materials Innovation, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
ORCID-Profile: Yoshiro Ito, Ayako Oyane
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ito, Y., Oyane, A., Matsumaru, Y., & Ishikawa, E. (2025). Basic Fibroblast Growth Factor‐Releasing Bioabsorbable Polyglycolic Acid Dura Mater Enhances Neural Progenitor Cell Proliferation and Neuroprotection After Brain Injury. Brain and Behavior. https://doi.org/10.1002/brb3.71008
Vancouver
Ito Y, Oyane A, Matsumaru Y, Ishikawa E. Basic Fibroblast Growth Factor‐Releasing Bioabsorbable Polyglycolic Acid Dura Mater Enhances Neural Progenitor Cell Proliferation and Neuroprotection After Brain Injury. Brain and Behavior. 2025. doi:10.1002/brb3.71008
BibTeX
@article{Ito2025,
author = {Ito, Yoshiro and Oyane, Ayako and Matsumaru, Yuji and Ishikawa, Eiichi},
title = {Basic Fibroblast Growth Factor‐Releasing Bioabsorbable Polyglycolic Acid Dura Mater Enhances Neural Progenitor Cell Proliferation and Neuroprotection After Brain Injury},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.71008}
}
EUVIMED